FCUV vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

FCUV

55.3
AI Score
VS
FCUV Wins

MLAB

39.8
AI Score

Investment Advisor Scores

FCUV

55score
Recommendation
HOLD

MLAB

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FCUV MLAB Winner
Revenue 723,143 60.14M MLAB
Net Income -2.77M 2.83M MLAB
Net Margin -382.4% 4.7% MLAB
Operating Income -2.82M 7.03M MLAB
ROE -33.7% 1.5% MLAB
ROA -13.8% 0.7% MLAB
Total Assets 20.03M 419.22M MLAB
Cash 1.60M 30.70M MLAB
Debt/Equity 2.20 0.35 MLAB
Current Ratio 2.44 1.79 FCUV
Free Cash Flow -8.55M 14.18M MLAB

Relative Price Performance (Last 90 Days)

FCUV 1M: -60.4% · 3M: +27.7% MLAB 1M: +3.1% · 3M: +22.5%

Current Technical Phase

FCUV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.5 · Price: $4.50

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.4% over 20 days), RSI 55

RSI (14): 54.8 · Price: $129.30

Fundamentals Snapshot

Metric FCUV MLAB
Market Cap — —
Forward P/E 0.0 24.0
Trailing P/E — 154.7
Revenue (TTM) — —
Revenue Growth 18.1% 0.0%
Gross Margin 0.3% 0.6%
Operating Margin -2.3% 0.1%
EPS -20.25 0.84
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, FCUV is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.